Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
PLoS One. 2010 Feb 16;5(2):e9226. doi: 10.1371/journal.pone.0009226.
Rabex-5 is a guanine nucleotide exchange factor (GEF) that specifically activates Rab5, i.e., converting Rab5-GDP to Rab5-GTP, through two distinct pathways to promote endosome fusion and endocytosis. The direct pathway involves a pool of membrane-associated Rabex-5 that targets to the membrane via an early endosomal targeting (EET) domain. The indirect pathway, on the other hand, involves a cytosolic pool of Rabex-5/Rabaptin-5 complex. The complex is recruited to the membrane via Rabaptin-5 binding to Rab5-GTP, suggesting a positive feedback mechanism. The relationship of these two pathways for Rab5 activation in the cell is unclear.
METHODOLOGY/PRINCIPAL FINDINGS: We dissect the relative contribution of each pathway to Rab5 activation via mathematical modeling and kinetic analysis in the cell. These studies show that the indirect pathway constitutes a positive feedback loop for converting Rab5-GDP to Rab5-GTP on the endosomal membrane and allows sensitive regulation of endosome fusion activity by the levels of Rab5 and Rabex-5 in the cell. The onset of this positive feedback effect, however, contains a threshold, which requires above endogenous levels of Rab5 or Rabex-5 in the cell. We term this novel phenomenon "delayed response". The presence of the direct pathway reduces the delay by increasing the basal level of Rab5-GTP, thus facilitates the function of the Rabex-5/Rabaptin-5-mediated positive feedback loop.
Our data support the mathematical model. With the model's guidance, the data reveal the affinity of Rabex-5/Rabaptin-5/Rab5-GTP interaction in the cell, which is quantitatively related to the Rabex-5 concentration for the onset of the indirect positive feedback pathway. The presence of the direct pathway and increased Rab5 concentration can reduce the Rabex-5 concentration required for the onset of the positive feedback loop. Thus the direct and indirect pathways cooperate in the regulation of early endosome fusion.
Rabex-5 是一种鸟嘌呤核苷酸交换因子(GEF),可通过两条不同的途径特异性激活 Rab5,即把 Rab5-GDP 转化为 Rab5-GTP,从而促进内体融合和内吞作用。直接途径涉及膜相关 Rabex-5 的池,该池通过早期内体靶向(EET)结构域靶向至膜。另一方面,间接途径涉及细胞质中 Rabex-5/Rabaptin-5 复合物池。该复合物通过 Rabaptin-5 与 Rab5-GTP 的结合被募集到膜上,这表明存在正反馈机制。在细胞中,两条途径对于 Rab5 激活的关系尚不清楚。
方法/主要发现:我们通过数学建模和细胞内动力学分析,剖析了每条途径对 Rab5 激活的相对贡献。这些研究表明,间接途径构成了在内体膜上将 Rab5-GDP 转化为 Rab5-GTP 的正反馈回路,并且可以通过细胞内 Rab5 和 Rabex-5 的水平来灵敏地调节内体融合活性。然而,这种正反馈效应的开始包含一个阈值,这需要细胞内 Rab5 或 Rabex-5 的水平高于内源性水平。我们将这种新的现象称为“延迟反应”。直接途径的存在通过增加 Rab5-GTP 的基础水平来减少延迟,从而促进 Rabex-5/Rabaptin-5 介导的正反馈回路的功能。
我们的数据支持数学模型。在模型的指导下,数据揭示了细胞中 Rabex-5/Rabaptin-5/Rab5-GTP 相互作用的亲和力,该亲和力与细胞中 Rabex-5 浓度定量相关,与间接正反馈途径开始所需的 Rabex-5 浓度相关。直接途径的存在和 Rab5 浓度的增加可以减少正反馈回路开始所需的 Rabex-5 浓度。因此,直接途径和间接途径在早期内体融合的调节中协作。